Visgenx, Inc. — Form D/A
Visgenx, Inc. of San Diego, CA, a company, filed a Form D amendment with the SEC on 2020-08-17. The offering totals $5.7M, of which $5.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-08-17
- Form: D/A
- Accession: 0001818870-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.7M
- Amount sold: $5.7M
- Investors: 30
- Date of first sale: 2020-05-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-367385
Issuer
- Name: Visgenx, Inc.
- CIK: 0001783776
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 3210 Merryfield Row, San Diego, CA, 92121
- Phone: 408-203-5023
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Frank Douglas, M.D., Ph.D. | Director | SAN DIEGO, CA |
| Santosh Vetticaden, M.D., Ph.D., MBA | Director | SAN DIEGO, CA |
| Santosh Vetticaden, M.D., Ph.D., MBA | Executive Officer | SAN DIEGO, CA |
| Arthur Becker | Director | Rowland Heights, CA |
| Martin Emanuele, Ph.D. | Director | San Diego, CA |
| Martin Emanuele, Ph.D. | Executive Officer | San Diego, CA |
| Thomas Meier, Ph.D., M.D. | Director | San Diego, CA |
| Elaine Heron, Ph.D. | Director | San Diego, CA |
| William Pedranti | Director | San Diego, CA |
| William Pedranti | Executive Officer | San Diego, CA |
| Santosh Vetticaden, Ph.D., M.D. | Director | San Diego, CA |
| Eric Carter, Ph.D., M.D. | Director | San Diego, CA |
| Frank Douglas | Director | Montvale, NJ |
| Santosh Vetticaden | Director | SAN DIEGO, CA |
| Santosh Vetticaden | Executive Officer | SAN DIEGO, CA |
| Martin Emanuele | Director | SAN DIEGO, CA |
| Martin Emanuele | Executive Officer | SAN DIEGO, CA |
Other filings by this issuer (3)
More